Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jun 6;15(27):10659-10667.
doi: 10.1039/d4sc01084a. eCollection 2024 Jul 10.

Divergent functionalization of alkenes enabled by photoredox activation of CDFA and α-halo carboxylic acids

Affiliations

Divergent functionalization of alkenes enabled by photoredox activation of CDFA and α-halo carboxylic acids

Rahul Giri et al. Chem Sci. .

Abstract

Herein we present our studies on the solvent-controlled difunctionalization of alkenes utilizing chlorodifluoroacetic acid (CDFA) and α-halo carboxylic acids for the synthesis of γ-lactones, γ-lactams and α,α-difluoroesters. Mechanistic insights revealed that photocatalytic reductive mesolytic cleavage of the C-X bond delivers elusive α-carboxyl alkyl radicals. In the presence of an olefin molecule, this species acts as a unique bifunctional intermediate allowing for stipulated formation of C-O, C-N and C-H bonds on Giese-type adducts via single electron transfer (SET) or hydrogen atom transfer (HAT) events. These protocols exhibit great efficiency across a broad spectrum of readily available α-halo carboxylic acids and are amenable to scalability in both batch and flow. To demonstrate the versatility of this concept, the synthesis of (±)-boivinianin A, its fluorinated analog and eupomatilone-6 natural products was successfully accomplished.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts to declare.

Figures

Scheme 1
Scheme 1. Introduction: (A) (bio)isostere of the CF2 group; (B) notable examples of gem-difluoro (CF2) containing biorelevant structures; (C) philicity trend of ˙CF2R free radicals; (D) our photoredox methods to access fluorinated compounds from alkenes.
Scheme 2
Scheme 2. Reaction scope: [a] conditions 1: alkene (1 equiv.), fac-Ir(ppy)3 (1 mol%), CDFA (2 equiv.), DMF (0.5 M), blue LEDs, rt, 12 h. [b] Conditions 2: alkene (1 equiv.), fac-Ir(ppy)3 (1 mol%), CDFA (2 equiv.), MeCN (0.17 M), Boc anhydride (2 equiv.), blue LEDs, rt, 24 h. [c] Conditions 3: alkene (1 equiv.), photocatalyst (1 mol%), CDFA (2 equiv.), VII (2 equiv.), alcohol : MeCN (1 : 1 v/v), blue LEDs, rt, 12 h; (A) scope of γ-lactams. (B) Scope of γ-lactones. (C) Scope of α,α-difluoroesters.
Scheme 3
Scheme 3. Reaction scope: [a] conditions 1: alkene (1 equiv.), fac-Ir(ppy)3 (1 mol%), acid (2 equiv.), DMF (0.5 M), blue LEDs, rt, 12 h; [b] conditions 2: alkene (1 equiv.), fac-Ir(ppy)3 (1 mol%), acid (2 equiv.), MeCN (0.17 M), Boc anhydride (2 equiv.), blue LEDs, rt, 24 h; (A) scope of α-halo carboxylic acids; (B) natural product synthesis.
Scheme 4
Scheme 4. Proposed mechanism: (A) proposed mechanism; (B) mechanistic studies towards formation of 1 and 2; (C) control experiments; (D) batch and flow scale-up. [a] Conditions 1: alkene (1 equiv.), fac-Ir(ppy)3 (1 mol%), CDFA (2 equiv.), DMF (0.5 M), blue LEDs rt, 12 h; [b] conditions 2: alkene (1 equiv.), fac-Ir(ppy)3 (1 mol%), CDFA (2 equiv.), MeCN (0.17 M), Boc anhydride (2 equiv.), blue LEDs, rt, 12 h; [c] alkene (10 mmol), fac-Ir(ppy)3 (0.1 mmol), CDFA (20 mmol), DMF (10 mL), blue LEDs, rt, 24 h, isolated yields; [d] alkene (20 mmol), fac-Ir(ppy)3 (0.2 mmol), CDFA (40 mmol), DMF (20 mL), flow rate = 0.3 mL min−1, τR = 2 h, isolated yields.

Similar articles

Cited by

References

    1. Shabir G. Saeed A. Zahid W. Naseer F. Riaz Z. Khalil N. Muneeba Albericio F. Pharmaceuticals. 2023;16:1162. doi: 10.3390/ph16081162. - DOI - PMC - PubMed
    1. Inoue M. Sumii Y. Shibata N. ACS Omega. 2020;5:10633–10640. doi: 10.1021/acsomega.0c00830. - DOI - PMC - PubMed
    1. Ogawa Y. Tokunaga E. Kobayashi O. Hirai K. Shibata N. iScience. 2020;23:101467. doi: 10.1016/j.isci.2020.101467. - DOI - PMC - PubMed
    1. Zhou Y. Wang J. Gu Z. Wang S. Zhu W. Aceña J. L. Soloshonok V. A. Izawa K. Liu H. Chem. Rev. 2016;116:422–518. doi: 10.1021/acs.chemrev.5b00392. - DOI - PubMed
    1. Meanwell N. A. J. Med. Chem. 2011;54:2529–2591. doi: 10.1021/jm1013693. - DOI - PubMed